Looking Beyond Component Quality for Sensitive Biologic Injectables
This webinar looks beyond the quality of individual closure components to explore what makes a primary packaging strategy successful for sensitive biologic injectables. Michel Pittet, Camille Dumas and Marco Milan from UCB will join Aptar Pharma’s Estelle Verger and Nicolas Voisin to discuss how upstream quality, contamination control and supply resilience can support better primary packaging decisions for injectable therapies.
Thursday, 19 November 2026
Why attend?
Primary packaging decisions for sensitive biologic injectables go beyond the technical performance of individual elastomeric closure solutions, such as vial stoppers and pre-filled syringe plungers. Consistency, drug product compatibility and continuity of supply can affect the drug product, manufacturing operations and ultimately the patient.
In this 360° dialogue, experts from UCB and Aptar Pharma bring the drug manufacturer and primary packaging perspectives to the same table. They will explore how upstream quality, contamination control, platform strategies, multisourcing and packaging flexibility can strengthen performance and supply resilience across different injectable products and manufacturing environments.
Participants will gain a practical framework for evaluating primary packaging closure components and partners, identifying potential gaps and aligning quality, technical and supply requirements earlier in the product lifecycle.
What Participants Will Learn
- What to consider when selecting elastomeric closure solutions for sensitive biologic injectables, and how these considerations can guide packaging decisions across injectable therapies.
- How to evaluate primary packaging solutions and partners using a 360° framework connecting component performance, upstream quality, platform fit, flexibility and supply resilience.
- Which questions to ask from pharmaceutical and primary packaging perspectives to identify quality, technical and supply risks earlier in packaging selection and qualification.